Keystone logo
Universidade Santiago de Compostela PhD in Drug Research and Development
Universidade Santiago de Compostela

PhD in Drug Research and Development

Santiago de Compostela, Spain

3 Years

Spanish, Galician

Full time

Request application deadline

Oct 2024

EUR 200 / per year

On-Campus

Introduction

Research in the field of biomedicine and pharmacy provides a solid foundation for the advancement of medicine. The introduction into the market of new drugs quickly and continuously, new active substances or new pharmaceutical forms are allowing to extend the life of patents (and with this the return on investment that, for pharmaceutical laboratories, represents the launch of new drugs to the market). These are some of the main challenges facing the pharmaceutical industry. This situation justifies the need to train doctors in the field of Drug Research and Development who are capable of carrying out their future activity in research centers or of becoming professionals who join pharmaceutical companies and the like.

The Doctoral Program in Research and Development of Medicines has been positively verified by the Council of Universities (on July 15, 2009) and has obtained the Mention towards Excellence (MEE) to which doctoral programs that comply with very demanding quality standards, which the Doctorate Program in Medicines R&D has managed to overcome successfully (MEE2011-0097), also receiving the highest score of all USC doctoral programs (obtained score 93 / 100). This circumstance has meant that the demand for students in this Program has increased in recent years, which shows its interest for society.

Likewise, as an index of the quality of the program, we can also highlight the fact that the PhD in Drug R&D has had a stable and high number of enrolled students, the number of Doctoral Theses defended with levels being also very high. very high quality. Likewise, the gradual increase in the number of theses defended as European Doctorates should be noted, which logically implies, on the one hand, the carrying out of research stays in laboratories of other prestigious European universities by doctoral students but, In addition, the need both to submit the work carried out to an evaluation process prior to the defense by international experts, as well as to have experts from other countries in the Court in charge of judging the work carried out, without forgetting that the act of defense It must be done in a language other than Spanish.

During all these years, to raise the level of quality of the activities carried out in the program, it has been usual to have the collaboration of outstanding external professors and researchers, both from universities and pharmaceutical laboratories, national and foreign and that, in some cases They collaborate closely with the professors and researchers integrated in the research groups in charge of the development of the doctoral program. For this, it has had both funding from the USC's own grants as well as those established by the MEC to promote the mobility of teachers and students in Doctoral Programs with a Quality Mention. After awarding the Mention to Excellence, the MEC has subsidized the participation of various European professors in doctoral activities and the travel of several doctoral students to other universities, most of them European, to carry out research stays related to their projects. thesis.

The program is widely accepted internationally, as evidenced by the high percentage of foreign students, mostly from European and South American countries, who have completed their doctorates within it.

Lines of investigation

  • Dosage forms and advanced systems for the administration of drugs, vaccines and genetic material in the prevention, diagnosis and treatment of diseases
  • Nanostructured materials and systems for tissue engineering and cell therapy
  • Molecular and cellular bases and clinical aspects involved in pathogenesis and in drug research and development

Ideal Students

Admissions

Curriculum

About the School

Questions